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Abstract
Biofilms are now considered ubiquitous in the natural world. Bacterial biofilms have
been observed to be extremely heterogeneous, both structurally and with regard to the
physiology of the bacterial cells within them. The prevailing conceptual model depicts bacterial
biofilms as being made up of microcolonies, which serve as the basic unit of the greater biofilm
structure. A major concern with this approach is the frequently observed development of
resistance to antimicrobial compounds. A number of elements in the process of biofilm
formation have been studied as targets for novel drug delivery technologies. The present study
aimed to penetrate biofilm by gram positive and gram negative bacteria by in-vitro culture
technique, with developed nano emulsion containing photodynamic agents. The results of this
study are encouraged and significantly prevent the formation of microcolonies, building bocks
of biofilms.

Introduction
Bio-films are defined as collection of organisms ( microcolonies) which are attached to a
surface by a matrix. This matrix is called as Extracellular Polymeric Substances (EPS). It has
good protection against macrophages and antibiotics which allows surviving even in hostile
environment. Due to their resistant phenotype it is difficult to eradicate. Attaching to the wet
surface is the natural tendency of microbes and after attaching they manufacture a protective
carbohydrate matrix which allows to attach to each other and to host wound surface3. Bio films
are found in Chronic wounds9. There are number of mechanisms by which various microbial
species are able to attach to a surface and promote cell-cell interactions and grow as a complex
structures called biofilms.
Formation of Biofilm occurs in a sequence of steps . They are Attachment of bacteria to
a solid surface, Proliferation and accumulation in multilayer cell cluster, Formation of bacterial
community enclosed in a self-produced polymeric matrix5. Attachment of microorganisms to
surface and biofilm development are very complex processes and affected by several variables.
Generally attachment occurs on surfaces that are rough , more hydrophobic and coated surface
conditioning film. Cell surface property, particularly the presence of extra cellular appendages ,
the interaction involved in cell-cell communication and EPS production are important for the
formation and development of biofilm7. Hydrophobicity of cell surface is important in adhesion
as hydrophobic interaction tends to increase with an increasing non-polar nature of one or both
surfaces involved.

Extracellular Polymeric Substances is responsible for binding cells and other particulate
material together and to the surface. EPS composes of polysaccharides , proteins , nucleic acids ,
lipids , phospholipids and humic substances. Proteins and phospholipids are the major
components of EPS . EPS acts as barrier and tolerate high amount of biocides and also delays or
prevents antimicrobials reaching target microorganisms by diffusion limitation6. Lipids and
nucleic acids influence the rheological properties and the stability of the biofilm significantly.
Extracellular DNA required for initial establishment of biofilm. Cell-Cell communication is a
driving force for self-organization and co-operation among the cells. These signals governors
cell attachment and detachment , facilitates their adaption to change in environment . They
respond to external environment and modulate their gene expression accordingly. Bacteria
produce diffusible organic signals called auto inducer (AI) molecules which accumulate in
surrounding environment. Their functions are extracellular enzymes biosynthesis, biofilm
development, antibiotic biosynthesis, bio surfactant production and EPS synthesis.
There are different methods in treating biofilm on wound , they are differentiated in to
mechanical debridement and chemical debridement. Mechanical Debriement is to completely
removing all necrotic tissues and biofilm in the wound bed while leaving tissues untouched.
Hydro surgery7 can be used in which debridement of wound tissue is done by both cutting and
aspirating the necrotic soft tissue. Wound dressing can also be done to remove the moisture
content in wound. Commercial antimicrobial and topical enzymatic agents used in wound care
cannot penetrate into biofilm and cannot eliminate critical wound bacterial colonization and
stimulate wound healing. Chemical Debridement is using of agents like silver and bleach
containing compounds and antibiotic can provide bactericidal effect with biofilm. Silver coating

cam also be done to prevent biofilm formation on industrial equipment. Ionic silver has a effect
in wound care due to interference with the transport system of biofilm.
But the above mentioned techniques helps in treatment of biofilms only to an extent and
they cannot prevent the reoccurrence of the bacterial biofilms . The use of non-invasive
Photodynamic Antimicrobial Chemotherapy (PACT) can overcome most of the problems which
are associated with the biofilms. The principle of PACT is the same as the traditional
photodynamic therapy . this is a non-intrusive technique that uses a combination of light and
non-toxic drug (photosensitizer) to destroy targeted cells. The inactive drug is activated by
irradiation at certain wave length producing reactive oxygen species , which destroys the targeted
cells without causing much damage to healthy cells. Once the irradiation is stopped the
photosensitive drug gets back into its intial inactive form. The main limitation of photodynamic
therapy is the uptake kinetics of the inactive drug by the micro organisms. Neutral , cationic and
anionic photosensitizers are effective on gram positive bacteria19 and where as hydrophilic
cationic photosensitizers are effective on gram negative bacteria. Gram negative bacteria are
more resistant because of their cell envelope and the outer membrane which provides very good
protection against environment and antibiotics. Nano emulsion studies are found to be efficient
in biological applications

which have good efficacy in solubilization and targeted drug

delivery15-17. In the present study we formulated different formulations of nano emulsions and we
have grown biofilm in
biofilms.

invitro conditions and successfully tested the formulations on the

Experimental Methods and Procedures

The biofilm of E coli (Gram negative) are successfully grown using CDC Bio-Reactor.
•

Bio-reactor is a one liter vessel with an effluent spout at approximately 400 ml.

•

A 5 gallons of diluted broth is made to run through the bio reactor continuously for 24 to
72 hrs till the formation of bio film.

•

Continuous mixing of the reactor’s bulk fluid is provided by a baffled stir bar that is
magnetically driven.

•

An UHMW polyethylene top supports eight independent rods. Each rod houses three
removable coupons (biofilm growth surfaces) for a total of 24 sampling opportunities.

•

The bioreactor operates as a continuous flow stirred tank reactor, as such nutrients are
continuously pumped into and flow out of the reactor, leaving only biofilm.

•

The bioreactor provides opportunity for checking the samples periodically . The bio film
growth can be checked from 24 hrs from the starting time and for every hour .

•

The samples also can collected periodically depending on the experimental conditions .

•

The used broth can also be collected and disposed off safely without any kind of
contamination.

Preparation of Nanoemulsion Formulations
The nanoemulsion drug is being prepared for optimal drug delivery. We have chosen
hydrophobic photosensitizers which are less permeable to cross the cell barrier. Many studies
have shown that using nanoemulsions as carriers for biomedical applications can improve
efficacy in solubilizing, protecting, and targeting microorganisms for specified delivery.
Therefore one can anticipate that our approach can greatly advance current chronic wound
treatment.
In this study we have chosen copper Phthalocyanine (CuPc) and riboflavin (vitamin
B2) as hydrophobic photosensitizers. The main reason for using this as a PACT agent is owing to
the certainty of its non-toxic nature towards human tissue. In order to promote the drug delivery
oil-in-water nanoemulsion formulations have been developed.
Preparation of oil in water (o/w) nanoemulsion
Formulation 1
In this formulation we use Copper phthalocyanine (CuPc) which will have a final oil phase.
•

Dissolve 5.0 mg of copper phthalocyanine (CuPc) and 2.0 mL of surfynol-465

(surfactant, wetting agent) in 20 mL of ethyl acetate (organic phase) over low heat with constant
stirring.
•

2 gm of poly ethylene glycol (PEG200) is dissolved in 20 mL of water (water phase).

•

Add the organic phase into water phase drop by drop with vigorously stirring over low

flame until all the ethyl acetate has evaporated.
•

Sonicate for 20 minutes.

Preparation of water in oil in water (w/o/w) nanoemulsion
•

A water-oil-water (w/o/w) double emulsion method is developed to entrap hydrophilic

vitamin riboflavin inside the double coated nanoparticles.
Formulation 2
•

In this formulation we use riboflavin (vitamin B2), as photosensitizer.

•

First 30 mg of riboflavin and 2.0g poly ethylene glycol (PEG 200) is dissolved in 20 mL

of water (water phase).
•

Dissolve 20 mL of castor oil and 2.0mL of surfynol-465 (organic phase) over low heat

with constant stirring.
•

The water phase is added drop by drop into the organic phase with constant stirring,

reverse micelles are formed in this step (w/o emulsion).
•

The final water phase is prepared by dissolving 2.0mL of polysorbate80 (surfactant) in 20

mL of water.
•

Finally, the w/o emulsion from above is added drop by drop into the final water phase

with constant stirring.
•

Keep stirring until all the water is evaporated, a double emulsion is formed in this step.

•

Surfynol-PEG is good pair of hydrophobic-hydrophilic double emulsion.

Formulation 3
•

In this formulation we use riboflavin (vitamin B2), nanoparticles.

•

First 30 mg of riboflavin and 2.0g poly ethylene glycol (PEG 200) is dissolved in 20 mL

of water (water phase).
•

Dissolve 20 mL of castor oil and 2.0mL of surfynol-465 (organic phase) over low heat

with constant stirring.
•

The water phase is added drop by drop into the organic phase with constant stirring,

reverse micelles are formed in this step (w/o emulsion).
•

The final water phase is prepared by dissolving 2.0mL of poloxamer-407 in 20 mL of

water.
•

Finally, the w/o emulsion from above is added drop by drop into the final water phase

with constant stirring.
•

Keep stirring until all the water is evaporated, a double emulsion is formed in this step.

•

Surfynol-PEG and Surfynol-Poloxamer-407 are all good pairs for a hydrophobic-

hydrophilic double emulsion.
The grown biofilm coupons are removed and drop each emulsion formulations on the top
of the coupon and each coupon is placed in a test tube containing TSB.

Half of the test tubes are kept in dark (that means covering the test tube with aluminum
foil to prevent exposure to light) and the other half are incubated for 30 minutes at 35˚C and then
irradiated to light for 30 minutes. The test tubes that are kept in dark and irradiated to light are
incubated for 24 hours.

Serial dilution is made 9x times with each test tube for counting of the bacteria .Four test
tubes, each with 9 mL of sterile tryptic soy broth, and labelled from 1to4. Then 1 mL sample is
taken from the bacterial suspension(test tube with coupon) that we wish to count and add it to
the first tube. Mix well, this is 1:10 dilution ratio because we have added 1 mL to 10mL total.
Then 1mLof dilution broth suspension is removed from tube 1 and added to tube 2. Mix well,
this dilution and each following mix increasingly will be diluted by a factor of 10. Thus, tube 2 is
1:100 dilutions. Then 1mLof dilution broth suspension is removed from tube 2 and added to tube
3 and mixed well. The same dilutions are followed for all the test tubes. Then 1mLof dilution
broth suspension is taken from tube 4 and added it to the surface of sterile nutrient medium in a
Petri dish. Spread evenly and incubate the plates upsides down allow the bacteria to multiply for
24 to 48 hours at 37˚C.

Results & Discussion
The Petri plate after incubating to 24 to 48 hours, the bacterial colonies that grew on the plates
are counted.
Formulation 1
We have seen that for formulation 1(copper phalocyanin) the bacterial cell count for the
Petri plates that has sample from test tubes kept in dark are 92 cells and for the Petri plates that
have samples from test tubes kept in light have no growth i.e 0 cells. Thus the percentage of
bacteria that are killed is calculated as the number of colonies on the plate times the reciprocal of
dilution factor gives the percentage of killing the microorganisms.
Therefore the formulation 1 has killed all the bacteria , almost 100%.
Formulation 2
We have seen that for formulation 2 (Riboflavin with polysorbate80 as surfactant) the
bacterial cell count for the Petri plates that have sample from test tubes kept in dark have 147
cells and for the Petri plates that have samples from test tubes kept in light have 0 cells.
Therefore we can say that the formulation 2 also have prevented the growth of bacteria upto
100%
Formulation 3
We have seen that for formulation 3 (riboflavin with poloxamer-407 as surfactant) the
bacterial cell count for the Petri plates that have saples from test tubes kept in dark have 897
cells and for the Petri plates that have samples from test tubes kept in light have 142cells. The

percentage of bacteria that is killed is calculated and the percentage of the prevention of growing
of bacteria is 84.2% .

Figure1
The following figures are the Petri plates which are after incubation to 37˚C.

Figure 2 : SEM Images of biofilm

The results shows that concentration of 5.0 mg of copper pthalocyanin can kill 100% of
bacteria after incubation followed by 0.5 h of irradiation with low intensity light, ~5.0 J/cm2 and
a concentration of 30 mg Riboflavin with polysorbate 80 as a surfactant can kill 100% of
bacteria, where as the concentration of 30mg Riboflavin with poloxamer-407 as a surfactant can
kill only 84.2% . This condition in using riboflavin is due to the less penetration of the drug with
poloxamer-407 as a surfactant. Hereby we can say that

the nanoemulsions formulated can

easily pass through the bacterial membrane releasing the photosensitizers which when activated
producing reactive oxygen species killing the bacteria inside the biofilm.
Table 1 : Results of formulations used on biofilm coupons kept in light and dark

Formulation 1

Formulation 2

(copper pthalocyanin)

(Riboflavin

Formulation3
with (Riboflavin

polysorbate80)

poloxamer-407)

Concentration

0.001

0.03

0.03

Dark

92 cells

147 cells

142 cells

Light

0 cells

0 cells

897 cells

% Kills

100%

100%

84.2%

with

Conclusion
From the above results we can assume that photodynamic antimicrobial chemotherapy
(PACT) has the potential to represent an alternative antibacterial treatment for drug-resistant
organisms. PDT uses normal visible light and nontoxic vitamin photosensitizer to destroy
specific targeted cells. Nano emulsions, that we formulated are very much effective in drug
delivery across the biofilms. We have developed a nanoemulsion in such a way to increase the
solubility of these drugs which are otherwise hard to dissolve hydrophobic vitamins for the
faster and more effective delivery to the targeted cells. Therefore the experimental procedure
and results provides a photodynamic chemotherapeutic regime for the treatment of chronic
wound ulcers by microbial biofilm.
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